CVR number 41815302
Industry 68.2010 Renting and operating of own or leased real estate

NIH ejendomme ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.4% 0.4% 0.4% 0.4% 0.4%  
Bankruptcy risk  0.0% 4.5% 2.9% 3.1% 3.0%  
Credit score (0-100)  0 46 57 56 56  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 103 337 331 376  
EBITDA  0.0 103 337 331 376  
EBIT  0.0 83.3 281 260 308  
Pre-tax profit (PTP)  0.0 45.4 178.2 87.8 43.5  
Net earnings  0.0 34.7 139.0 68.2 33.9  
Pre-tax profit without non-rec. items  0.0 45.4 178 87.8 43.5  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 4,007 7,130 7,059 6,991  
Shareholders equity total  0.0 74.7 1,674 1,667 1,701  
Interest-bearing liabilities  0.0 3,646 5,259 216 184  
Balance sheet total (assets)  0.0 4,054 7,206 7,149 7,071  
Net Debt  0.0 3,611 5,205 146 139  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 103 337 331 376  
Gross profit growth  0.0% 0.0% 225.8% -1.6% 13.5%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 4,054 7,206 7,149 7,071  
Balance sheet change%  0.0% 0.0% 77.7% -0.8% -1.1%  
Added value  0.0 103.4 336.8 315.8 376.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 3,987 3,067 -142 -137  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 80.5% 83.4% 78.5% 81.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 2.1% 5.0% 3.6% 4.3%  
ROI %  0.0% 2.2% 5.4% 3.8% 4.3%  
ROE %  0.0% 46.4% 15.9% 4.1% 2.0%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 1.8% 23.2% 23.3% 24.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 3,493.8% 1,545.7% 44.1% 36.9%  
Gearing %  0.0% 4,883.0% 314.2% 12.9% 10.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.1% 2.3% 6.3% 132.3%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.1 0.2 0.7 0.8  
Current Ratio  0.0 0.1 0.2 0.7 0.8  
Cash and cash equivalent  0.0 34.8 53.6 69.5 45.0  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -701.8 -335.5 -42.1 -25.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0